Skip to main content
Fig. 4 | Orphanet Journal of Rare Diseases

Fig. 4

From: Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age – a multicenter retrospective study

Fig. 4

SEGA development under everolimus treatment. Axial and coronal T2-weighted and T1-weighted with gadolinium MRI sections of 6 patients treated with everolimus for SEGA. All patients were diagnosed with SEGA at risk for development of obstructive hydrocephalus at baseline (left column). On follow-up in 5/6 patients marked reduction of SEGA volume was documented (patient #1, 3, 4, 9, 12, right column). In patient #8 SEGA size remained unchanged after initiation of everolimus treatment (right column)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172